Insider Trading
Track Major Insider Updates On X/Twitter
LH Stock Insider Trading Activity
Corporate insiders are required to disclose purchases or sales of their own stock within two business days of when they occur. Using these disclosures, we collect data on LH stock insider trading activity, which can give hints on whether executives are bullish or bearish on their own company.
Recent insider purchases and sales - LH
| Name / Title | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
|
EISENBERG GLENN A
Executive Vice President
|
Sale | 11711 | Dec 02, 2024 | Dec. 4, 2024, 10:59 a.m. |
|
Gilliland Dwight Gary
|
Sale | 1000 | Dec 02, 2024 | Dec. 4, 2024, 10:55 a.m. |
|
Summy Amy B.
EVP, Chief Marketing Officer
|
Sale | 3671 | Nov 22, 2024 | Nov. 26, 2024, 12:06 p.m. |
|
van der Vaart Sandra D
EVP, Chief Legal Officer
|
Sale | 1000 | Nov 21, 2024 | Nov. 25, 2024, 9:14 a.m. |
|
Schechter Adam H
President & CEO
|
Sale | 6189 | Nov 11, 2024 | Nov. 13, 2024, 9:16 a.m. |
|
ANDERSON KERRII B
|
Sale | 1000 | Oct 24, 2024 | Oct. 25, 2024, 9:26 a.m. |
|
van der Vaart Sandra D
EVP, Chief Legal Officer
|
Sale | 2000 | Aug 19, 2024 | Aug. 21, 2024, 9:08 a.m. |
|
EISENBERG GLENN A
Chief Financial Officer, EVP
|
Sale | 9071 | Aug 15, 2024 | Aug. 19, 2024, 10:22 a.m. |
|
EISENBERG GLENN A
Chief Financial Officer, EVP
|
Sale | 2950 | Aug 15, 2024 | Aug. 19, 2024, 10:22 a.m. |
|
EISENBERG GLENN A
Chief Financial Officer, EVP
|
Sale | 2979 | Aug 15, 2024 | Aug. 19, 2024, 10:22 a.m. |
|
ANDERSON KERRII B
|
Sale | 586 | Aug 08, 2024 | Aug. 9, 2024, 10:16 a.m. |
|
ANDERSON KERRII B
|
Sale | 414 | Aug 07, 2024 | Aug. 9, 2024, 10:16 a.m. |
|
BERBERIAN LANCE
EVP, CIO & CTO
|
Sale | 9848 | Aug 05, 2024 | Aug. 7, 2024, 8:47 a.m. |
|
BERBERIAN LANCE
EVP, CIO & CTO
|
Sale | 2245 | Aug 05, 2024 | Aug. 7, 2024, 8:47 a.m. |
|
van der Vaart Sandra D
EVP, Chief Legal Officer
|
Sale | 200 | May 14, 2024 | May 16, 2024, 8:02 a.m. |
|
van der Vaart Sandra D
EVP, Chief Legal Officer
|
Sale | 1800 | May 14, 2024 | May 16, 2024, 8:02 a.m. |
|
ANDERSON KERRII B
|
Sale | 250 | May 02, 2024 | May 2, 2024, 4:29 p.m. |
|
ANDERSON KERRII B
|
Sale | 250 | Apr 30, 2024 | May 2, 2024, 4:29 p.m. |
|
Wilkinson Peter J
SVP, Chief Accounting Officer
|
Sale | 2439 | Apr 29, 2024 | May 1, 2024, 6:29 p.m. |
|
Schroeder Mark S
EVP, Pres Diagnostics & COO
|
Sale | 6477 | Apr 01, 2024 | April 3, 2024, 8:35 a.m. |
|
Summy Amy B.
EVP, Chief Marketing Officer
|
Sale | 3500 | Apr 01, 2024 | April 3, 2024, 8:34 a.m. |
|
van der Vaart Sandra D
EVP, Chief Legal Officer
|
Sale | 3553 | Mar 28, 2024 | March 29, 2024, 5:54 p.m. |
|
Schroeder Mark S
EVP, Pres Diagnostics & COO
|
Sale | 5048 | Mar 07, 2024 | March 11, 2024, 8:59 a.m. |
|
Summy Amy B.
EVP, Chief Marketing Officer
|
Sale | 227 | Mar 07, 2024 | March 11, 2024, 8:56 a.m. |
|
EISENBERG GLENN A
Chief Financial Officer, EVP
|
Sale | 6665 | Feb 21, 2024 | Feb. 22, 2024, 4:05 p.m. |
|
EISENBERG GLENN A
Chief Financial Officer, EVP
|
Sale | 7907 | Feb 21, 2024 | Feb. 22, 2024, 4:05 p.m. |
|
EISENBERG GLENN A
Chief Financial Officer, EVP
|
Sale | 1553 | Feb 21, 2024 | Feb. 22, 2024, 4:05 p.m. |
|
EISENBERG GLENN A
Chief Financial Officer, EVP
|
Sale | 18379 | Feb 21, 2024 | Feb. 22, 2024, 4:05 p.m. |
|
DiVincenzo Jonathan P.
EVP, Pres, Central Labs & Intl
|
Sale | 500 | Feb 21, 2024 | Feb. 22, 2024, 4:04 p.m. |
|
van der Vaart Sandra D
EVP, Chief Legal Officer
|
Sale | 237 | Feb 13, 2024 | Feb. 15, 2024, 9:32 a.m. |
|
van der Vaart Sandra D
EVP, Chief Legal Officer
|
Sale | 259 | Feb 08, 2024 | Feb. 9, 2024, 1:19 p.m. |
|
van der Vaart Sandra D
EVP, Chief Legal Officer
|
Sale | 193 | Feb 05, 2024 | Feb. 6, 2024, 4:47 p.m. |
|
Wilkinson Peter J
SVP, Chief Accounting Officer
|
Sale | 1384 | Nov 16, 2023 | Nov. 20, 2023, 1:23 p.m. |
|
ANDERSON KERRII B
|
Sale | 5000 | Aug 08, 2023 | Aug. 10, 2023, 8:55 a.m. |
|
van der Vaart Sandra D
EVP, Chief Legal Officer
|
Sale | 212 | Jun 29, 2023 | July 3, 2023, 11:52 a.m. |
|
Kirchgraber Paul R
CEO, Covance Drug Development
|
Sale | 4300 | May 19, 2023 | May 23, 2023, 8:06 a.m. |
|
Schroeder Mark S
EVP, Pres Diagnostics & COO
|
Sale | 1500 | May 18, 2023 | May 22, 2023, 3:08 p.m. |
|
Schroeder Mark S
EVP, President-Diagnostics Lab
|
Sale | 3897 | Mar 31, 2023 | April 3, 2023, 10:05 a.m. |
|
Kirchgraber Paul R
CEO, Covance Drug Development
|
Sale | 8000 | Feb 21, 2023 | Feb. 23, 2023, 10:54 a.m. |
|
Schroeder Mark S
EVP, President-Diagnostics Lab
|
Sale | 309 | Feb 14, 2023 | Feb. 16, 2023, 1:51 p.m. |
|
van der Vaart Sandra D
EVP, Chief Legal Officer
|
Sale | 219 | Feb 07, 2023 | Feb. 9, 2023, 10:27 a.m. |
|
Schroeder Mark S
EVP, President-Diagnostics Lab
|
Sale | 409 | Feb 07, 2023 | Feb. 9, 2023, 10:04 a.m. |
|
van der Vaart Sandra D
EVP, Chief Legal Officer
|
Sale | 173 | Feb 03, 2023 | Feb. 6, 2023, 4:56 p.m. |
|
Schroeder Mark S
EVP, President-Diagnostics Lab
|
Sale | 324 | Feb 03, 2023 | Feb. 6, 2023, 4:51 p.m. |
|
Schroeder Mark S
EVP, President-Diagnostics Lab
|
Sale | 1116 | Nov 08, 2022 | Nov. 10, 2022, 9:40 a.m. |
|
EISENBERG GLENN A
Chief Financial Officer, EVP
|
Sale | 4844 | Sep 26, 2022 | Sept. 28, 2022, 9:12 a.m. |
|
EISENBERG GLENN A
Chief Financial Officer, EVP
|
Sale | 5627 | Sep 26, 2022 | Sept. 28, 2022, 9:12 a.m. |
|
EISENBERG GLENN A
Chief Financial Officer, EVP
|
Sale | 11699 | Sep 26, 2022 | Sept. 28, 2022, 9:12 a.m. |
|
EISENBERG GLENN A
Chief Financial Officer, EVP
|
Sale | 2830 | Sep 26, 2022 | Sept. 28, 2022, 9:12 a.m. |
|
Caveney Brian J
EVP, President of Diagnostics
|
Purchase | 44 | Sep 07, 2022 | Sept. 13, 2022, 11:39 a.m. |